GTS Securities’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,712
| Closed | -$226K | – | 1223 |
|
|
2024
Q3 | $226K | Sell |
14,712
-12,153
| -45% | -$187K | ﹤0.01% | 1477 |
|
|
2024
Q2 | $437K | Sell |
26,865
-30,711
| -53% | -$499K | ﹤0.01% | 1021 |
|
|
2024
Q1 | $1.06M | Buy |
57,576
+39,588
| +220% | +$732K | ﹤0.01% | 518 |
|
|
2023
Q4 | $563K | Sell |
17,988
-40,323
| -69% | -$1.26M | ﹤0.01% | 862 |
|
|
2023
Q3 | $1.22M | Buy |
+58,311
| New | +$1.22M | ﹤0.01% | 456 |
|